Physician profile
William J Stanton
NPI 1346316437
$4,148.11
in general payments reported to CMS, 2019-2025
9 companies · $943 in 2025
The $943 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,159 · 2022: $675 · 2023: $103 · 2024: $268 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991 · Travel and Lodging: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.55 |
| Travel and Lodging | $323.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,518.20 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $1,473.08 | 2021-2025 | Affixus |
| Stryker Corporation | $904.23 | 2021-2025 | Mako, Variax, Insignia |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Depuy Synthes Sales INC. | $69.82 | 2023-2024 | Orthovisc |
| Ermi LLC | $42.24 | 2024 | |
| Bioventus LLC | $22.38 | 2025 | Gelsyn-3 |
| Fidia Pharma USA INC. | $17.69 | 2023 | Hymovis, Triluron |
| Pacira Pharmaceuticals Incorporated | $16.55 | 2024 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.